butoxamine   Click here for help

GtoPdb Ligand ID: 9809

Compound class: Synthetic organic
Comment: beta-2 selective adrenergic antagonist
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 50.72
Molecular weight 267.18
XLogP 2.52
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC
Isomeric SMILES COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC
InChI InChI=1S/C15H25NO3/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6/h7-10,14,16-17H,1-6H3
InChI Key TWUSDDMONZULSC-UHFFFAOYSA-N
References
1. Baker JG. (2010)
The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
Br J Pharmacol, 160 (5): 1048-61. [PMID:20590599]
2. Brown DA, Dunn PM. (1983)
Depolarization of rat isolated superior cervical ganglia mediated by beta 2-adrenoceptors.
Br J Pharmacol, 79 (2): 429-39. [PMID:6140042]
3. Hillman KL, Doze VA, Porter JE. (2005)
Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
J Pharmacol Exp Ther, 314 (2): 561-7. [PMID:15908513]
4. Tsuchihashi H, Nakashima Y, Kinami J, Nagatomo T. (1990)
Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Jpn J Pharmacol, 52 (2): 195-200. [PMID:1968985]